We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

163 hedge funds and large institutions have $1.34B invested in Rocket Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

473% more call options, than puts

Call options by funds: $3.81M | Put options by funds: $664K

95% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 37

2.25% more ownership

Funds ownership: 96.38% → 98.63% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

3% less funds holding

Funds holding: 168 → 163 (-5)

8% less capital invested

Capital invested by funds: $1.46B → $1.34B (-$123M)

Holders
163
Holders Change
-5
Holders Change %
-2.98%
% of All Funds
2.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
72
Reduced
37
Closed
17
Calls
$3.81M
Puts
$664K
Net Calls
+$3.14M
Net Calls Change
-$12.1M

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$19.8M
2
Goldman Sachs
Goldman Sachs
New York
+$12.2M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$12.1M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.8M
5
EAM
Eventide Asset Management
Massachusetts
+$8.37M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$25M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$11.2M
3
N
Nuveen
North Carolina
-$6.86M
4
APM
Avidity Partners Management
Texas
-$5.54M
5
TM
Tiger Management
New York
-$5.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
151
SignatureFD
Georgia
$7.14K – – –
WAM
152
Wolverine Asset Management
Illinois
$6.83K – – –
TWA
153
TCI Wealth Advisors
Arizona
$5.69K – – –
Daiwa Securities Group
154
Daiwa Securities Group
Japan
$5K – – –
Northwestern Mutual Wealth Management
155
Northwestern Mutual Wealth Management
Wisconsin
$2.26K +$2.56K +131 +13,100%
QCG
156
Quadrant Capital Group
Ohio
$1.78K – – –
LC
157
Lindbrook Capital
California
$1.51K – – –
FHA
158
First Horizon Advisors
Tennessee
$890 – – –
IA
159
IFP Advisors
Florida
$496 – – –
MFG
160
Mendota Financial Group
Wisconsin
$397 -$392 -20 -44%
NFSG
161
Newbridge Financial Services Group
Florida
$308 – – –
VFA
162
Values First Advisors
Tennessee
$9 +$20 +1 New
TM
163
Tiger Management
New York
– -$5.47M -279,700 Closed
AAA
164
Affinity Asset Advisors
New York
– -$5.05M -258,115 Closed
GPCM
165
Granite Point Capital Management
Massachusetts
– -$2.74M -140,000 Closed
CM
166
Caption Management
Oklahoma
– -$2.54M -130,000 Closed
ABG
167
Ally Bridge Group
New York
– -$2.45M -125,176 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
168
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$1.6M -82,000 Closed
SSA
169
Schonfeld Strategic Advisors
New York
– -$999K -51,024 Closed
AG
170
Algert Global
California
– -$974K -49,768 Closed
NYLIM
171
New York Life Investment Management
New York
– -$700K -35,766 Closed
PM
172
Prosight Management
Texas
– -$630K -32,193 Closed
SMH
173
Sanders Morris Harris
Texas
– -$542K -27,709 Closed
XT
174
XTX Topco
Cayman Islands
– -$389K -19,859 Closed
Marshall Wace
175
Marshall Wace
United Kingdom
– -$264K -13,500 Closed
4 5 6
7
8

RCKT Hedge Fund Activity: Q1 2023 in Review

163 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q1 2023, worth a combined $1.34B — down 8.4% from $1.46B a quarter earlier.

Fund positioning in RCKT was balanced in Q1 2023: 17 funds opened new positions, 17 closed out, 72 added to existing stakes and 37 trimmed.

The largest buyer was Maverick Capital, adding an estimated $19.8M. The largest seller was RA Capital Management, cutting an estimated $25M.

  • 163 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q1 2023, down from 168 in Q4 2022.
  • Funds reported $1.34B of Rocket Pharmaceuticals stock for Q1 2023, down 8.4% quarter-over-quarter.
  • 17 funds opened new Rocket Pharmaceuticals positions in Q1 2023 and 17 closed out, a net change of 0 holders.
  • The largest Rocket Pharmaceuticals buyer in Q1 2023 was Maverick Capital, an estimated $19.8M added.
  • The largest Rocket Pharmaceuticals seller in Q1 2023 was RA Capital Management, an estimated $25M sold.

Based on aggregated 13F filings for Q1 2023.